Jesús Usón Minimally Invasive Surgery Centre (CCMIJU) at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Jesús Usón Minimally Invasive Surgery Centre (CCMIJU) brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on mesenchymal stromal cells taken from menstrual blood and how inflammatory priming changes them. The studies look at immune and hormone-related signatures relevant to endometriosis and a cardioprotective profile, alongside a review of stem cell therapy for endometriosis.
| Organization | ESGCT 2026 Attendance |
|---|---|
Jesús Usón Minimally Invasive Surgery Centre (CCMIJU) Cáceres, Spain | |
Biomedical research and training centre for minimally invasive surgery, with translational research in advanced therapies and a preclinical contract research service. | Poster Wed Oct 28 1:30pm–3:30pm Preclinical efficacy and safety determinants of stem cell-based therapies for endometriosis: a systematic review Cell therapies and CAR-T Poster Thu Oct 29 2:00pm–4:00pm Menstrual blood-derived MSCs under proinflammatory priming exhibit signatures associated with immunomodulatory and hormone-regulating pathways relevant to endometriosis Cell therapies and CAR-T Poster Thu Oct 29 2:00pm–4:00pm Pro-inflammatory priming promotes a cardioprotective-associated transcriptional profile in menstrual blood-derived MSCs |
Instantly find 20 buyers from Jesús Usón Minimally Invasive Surgery Centre (CCMIJU)
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction